欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/4234/001
药品名称Fulvestrant Teva 250 mg Injektionslösung in einer Fertigspritze
活性成分
    • Fulvestrant 250.0 mg
剂型Solution for injection in prefilled syringe
上市许可持有人ratiopharm GmbH Graf-Arco-Str. 3 89079 Ulm Germany
参考成员国 - 产品名称Germany (DE)
互认成员国 - 产品名称
    • Denmark (DK)
      Fulvestrant Teva
    • Belgium (BE)
      Fulvestrant Teva 250 mg oplossing voor injectie/solution injectable/ Injektionslösung
    • Netherlands (NL)
      Fulvestrant Teva 250 mg, oplossing voor injectie in een voorgevulde spuit
    • Luxembourg (LU)
    • Iceland (IS)
      Fulvestrant Teva 250 mg Stungulyf, lausn í áfylltri sprautu
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      Fulvestrant ratiopharm 250 mg Injektionslösung in einer Fertigspritze
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Sweden (SE)
    • Finland (FI)
    • Poland (PL)
    • Latvia (LV)
      Fulvestrant Teva 250 mg šķīdums injekcijām pilnšļircē
    • Lithuania (LT)
      Fulvestrant Teva 250 mg injekcinis tirpalas užpildytame švirkšte
    • Hungary (HU)
      FULVESTRANT TEVA 250 mg/5 ml oldatos injekció előretöltött fecskendőben
    • Bulgaria (BG)
      Fluvestrant Teva
    • Czechia (CZ)
      Fulvestrant Teva 250 mg
    • Romania (RO)
      FULVESTRANT TEVA 250 mg soluţie injectabilă în seringă preumplută
    • Slovakia (SK)
      Fulvestrant Teva 250 mg
    • Slovenia (SI)
    • Croatia (HR)
      Fulvestrant Pliva 250 mg otopina za injekciju u napunjenoj štrcaljki
许可日期2016/02/17
最近更新日期2024/11/25
药物ATC编码
    • L02BA03 fulvestrant
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase